USPTO serial 85032922
OPEN TTG
Reviewed by CopyMark Law Group
Reg. 3922441Status 710
- Filing date
- Status date
- Registration date
- Feb 22, 2011
- Examiner
- TOOLEY, DAVID E
- Law office
- TMO LAW OFFICE 112
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with OPEN TTG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Darmstadt, DE
Darmstadt, DE
Darmstadt, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Dwayne K. Goetzel
DWAYNE K. GOETZEL MEYERTONS, HOOD, KIVLIN, KOWERT & GOETZEL, P.C.P.O. Box 398AUSTIN, TX 78767-0398UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals and biochemicals used in industry and science, chemicals and biochemicals for apheresis | SECTION 8 - CANCELLED | — |
| 005 | Medicines, pharmaceutical, veterinary and sanitary preparations for the treatment, prophylaxis and diagnosis of diseases; (( pharmaceutical preparations in particular for the treatment, prophylaxis and diagnosis of autoimmune disorders, gluten-sensitive autoimmune disorders, coeliac disease, dermatitis herpetiformis, Duhring's disease, gluten-sensitive ataxia, food incompatibilities, intestinal disorders, irritable bowel syndrome, fibrosis, scar formation, hypertrophic scars, scleroderma, diabetic nephropathies, liver fibrosis, cirrhosis, lung fibrosis, arteriosclerosis, cancer, thrombolysis, acne, skin ageing, psoriasis, neurodegenerative disorders, Alzheimer's disease, Huntington's disease, Parkinson's disease, cataracts, affliction by micro-organisms, infections or candidosis; chemical and biochemical preparations for medicinal purposes, chemical and biochemical preparations for sanitary purposes, chemical and biochemical preparations for medical and veterinary purposes, all the aforementioned for the treatment, prophylaxis and diagnosis of autoimmune disorders, gluten-sensitive autoimmune disorders, coeliac disease, dermatitis herpetiformis, Duhring's disease, gluten-sensitive ataxia, food incompatibilities, intestinal disorders, irritable bowel syndrome, fibrosis, scar formation, hypertrophic scars, scleroderma, diabetic nephropathies, liver fibrosis, cirrhosis, lung fibrosis, arteriosclerosis, cancer, thrombolysis, acne, skin ageing, psoriasis, neurodegenerative disorders, Alzheimer's disease, Huntington's disease, Parkinson's disease, cataracts, affliction by micro-organisms, infections or candidosis; dietetic foods adapted for medical use and dietetic foods for medical and veterinary purposes; food supplements for medical purposes; disinfectants for sanitary purposes; preparations for destroying vermin; chemical and biochemical preparations for use in medical science for use in or on human and/or animal bodies for the treatment, prophylaxis and diagnosis of autoimmune disorders, gluten-sensitive autoimmune disorders, coeliac disease, dermatitis herpetiformis, Duhring's disease, gluten-sensitive ataxia, food incompatibilities, intestinal disorders, irritable bowel syndrome, fibrosis, scar formation, hypertrophic scars, scleroderma, diabetic nephropathies, liver fibrosis, cirrhosis, lung fibrosis, arteriosclerosis, cancer, thrombolysis, acne, skin ageing, psoriasis, neurodegenerative disorders, Alzheimer's disease, Huntington's disease, Parkinson's disease, cataracts, affliction by micro-organisms, infections or candidosis; diagnostic preparations for medical purposes; radiological contrast agents for medical purposes, germicidal detergents for medical purposes, pharmaceutical preparations for apheresis )) | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 24, 2021 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Feb 22, 2020 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Jan 25, 2017 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Jan 25, 2017 | NA15 | SEC. 15 ACKNOWLEDGEMENT - E-MAILED | — |
| Jan 25, 2017 | 15AK | REGISTERED - SEC. 15 ACKNOWLEDGED | — |
| Jan 25, 2017 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| Jan 25, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 12, 2017 | E15R | TEAS SECTION 15 RECEIVED | — |
| Jan 12, 2017 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Feb 22, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 7, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 7, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 2, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 2, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 2, 2010 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 2, 2010 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 2, 2010 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 2, 2010 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 1, 2010 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Nov 1, 2010 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Nov 1, 2010 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 1, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 1, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 1, 2010 | ALIE | ASSIGNED TO LIE | — |
| Sep 30, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 25, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 25, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 25, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 19, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| May 14, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 11, 2010 | NWAP | NEW APPLICATION ENTERED | — |